Ad is loading...
MENU
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harmony Biosciences Holdings (HRMY) Earnings Date & Reports

A.I. Advisor
published Earnings

HRMY is expected to report earnings to fall 15.15% to 67 cents per share on February 19

Harmony Biosciences Holdings HRMY Stock Earnings Reports
Q4'24
Est.
$0.67
Q3'24
Beat
by $0.12
Q2'24
Beat
by $1.04
Q1'24
Beat
by $0.25
Q4'23
Beat
by $0.01
The last earnings report on October 29 showed earnings per share of 79 cents, beating the estimate of 67 cents. With 598.33K shares outstanding, the current market capitalization sits at 1.89B.
View a ticker or compare two or three
HRMY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com